|
|
Volumn 25, Issue 2, 2007, Pages 161-164
|
|
Rebeccamycin analog for refractory breast cancer: A randomized phase II trial of dosing schedules
a
|
|
Author keywords
Breast cancer; Phase II; Rebeccamycin; Rebeccamycin analog
|
|
Indexed keywords
1,11 DICHLORO 6 (2 DIETHYLAMINOETHYL) 12,13 DIHYDRO 5H INDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE 5,7(6H) DIONE 13 (4 O METHYLGLUCOSIDE);
ANTHRACYCLINE;
ANTIBIOTIC AGENT;
CYTOTOXIC AGENT;
DEXAMETHASONE;
ETOPOSIDE;
FLUOROURACIL;
LORAZEPAM;
ONDANSETRON;
PROCHLORPERAZINE;
REBECCAMYCIN;
REBECCAMYCIN DERIVATIVE;
TAXANE DERIVATIVE;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ANEMIA;
ANOREXIA;
ARTICLE;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER GROWTH;
CANCER RECURRENCE;
CENTRAL VENOUS CATHETER;
CHEMOTHERAPY INDUCED EMESIS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG DOSE COMPARISON;
DRUG TOLERABILITY;
DYSGEUSIA;
DYSPNEA;
FATIGUE;
FEBRILE NEUTROPENIA;
FEMALE;
HUMAN;
INFECTION;
MULTIPLE CYCLE TREATMENT;
NAUSEA;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RASH;
THROMBOCYTOPENIA;
TREATMENT RESPONSE;
ADULT;
AGED;
ANTIBIOTICS, ANTINEOPLASTIC;
BLOOD CELL COUNT;
BREAST NEOPLASMS;
CARBAZOLES;
DISEASE PROGRESSION;
DRUG RESISTANCE, NEOPLASM;
ENDPOINT DETERMINATION;
FEMALE;
HUMANS;
INDOLES;
MIDDLE AGED;
|
|
EID: 33845901798
PISSN: 01676997
EISSN: None
Source Type: Journal
DOI: 10.1007/s10637-006-9007-6 Document Type: Article |
|
Times cited : (20)
|
|
References (8)
|
